Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2026)
Hims & Hers Health (HIMS) posted Share-based Compensation of $39.2 million for Q1 2026, down 2.69% sequentially from $40.3 million in Q4 2025, and up 52.49% YoY from $25.7 million in Q1 2025.
Hims & Hers Health (HIMS) Share-based Compensation (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Share-based Compensation for 7 years, with the latest figure at $39.2 million in Q1 2026.
- Quarterly Share-based Compensation rose 52.49% year-over-year to $39.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.7 million (up 151.33% YoY) and the FY2025 annual result came in at $135.2 million, up 157.6% from the prior year.
- Share-based Compensation fell to $39.2 million in Q1 2026 per HIMS's latest filing, from $40.3 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $40.3 million in Q4 2025 and troughed at -$30.4 million in Q3 2023.
- A 5-year average of $14.7 million and a median of $19.1 million in 2022 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation sank 377.08% in 2023, then soared 973.35% in 2025.
- Over 5 years, Share-based Compensation stood at -$29.3 million in 2022, then surged by 119.41% to $5.7 million in 2023, then surged by 241.7% to $19.4 million in 2024, then surged by 107.62% to $40.3 million in 2025, then retreated by 2.69% to $39.2 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $39.2 million, $40.3 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 39.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.77 Mn |
| Jun 30, 2026 | 39.77 Mn |
| Mar 31, 2026 | 39.21 Mn |
| Mar 31, 2026 | 39.21 Mn |
| Dec 31, 2025 | 40.29 Mn |
| Dec 31, 2025 | 40.29 Mn |
| Sep 30, 2025 | 34.37 Mn |
| Sep 30, 2025 | 34.37 Mn |
| Jun 30, 2025 | 34.87 Mn |
| Jun 30, 2025 | 34.87 Mn |
| Mar 31, 2025 | 25.71 Mn |
| Mar 31, 2025 | 25.71 Mn |
| Dec 31, 2024 | 19.41 Mn |
| Dec 31, 2024 | 19.41 Mn |
| Sep 30, 2024 | 10.82 Mn |
| Sep 30, 2024 | 10.82 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 19.03 Mn |
| Mar 31, 2024 | 19.03 Mn |